Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Update on DeepVerge Collaboration

21 Oct 2021 07:00

RNS Number : 7339P
Microsaic Systems plc
21 October 2021
 

21 October 2021

 

Microsaic Systems plc

("Microsaic" or the "Company")

Update on DeepVerge Collaboration

 

Microsaic (AIM: MSYS), is pleased to note the update by DeepVerge plc (AIM: DVRG) ("DeepVerge") provided today regarding their orders for pathogen monitoring equipment for shipment this year to partners and customers in UK, India and China, which includes upgrades to DeepVerge Modern Water Microtox® PD1 units and Microsaic mass spectrometer units. Configurations of the Microsaic equipment will be included in these orders to DeepVerge for the integrated detection of PFASs (Per- and Polyfluoroalkyl Substances or 'forever chemicals'), as referenced in previous Microsaic announcements on 25 May and 23 August, 2021. This monitoring capability forms part of broader integrated solutions offered by DeepVerge for monitoring toxicity and heavy metal pollutants as well as the prevalence of SARS-CoV-2 as part of the ongoing pandemic response.

Glenn Tracey, CEO of Microsaic commented:

"We are greatly encouraged to see the results of our collaboration with DeepVerge translating into early demand for Microsaic mass spectrometer units as part of a new point-of-need monitoring solution, providing the capability for real-time monitoring of PFASs or 'Forever Chemicals'. In addition, working with DeepVerge teams in York, UK and Cork, Ireland we can already see an important contribution being made in the use of our micro-engineering expertise in ongoing development and upgrading of DeepVerge Modern Water equipment, especially in the integrated approach to Artificial Intelligence ("AI") between our technologies.

"While small in terms of initial impact for Microsaic, we see these initial shipments as having the potential to seed further demand in key locations, particularly in India and China over time. The power of these surveillance solutions lies in their multi-tiered approach to environmental monitoring and control, from pandemic response (pathogen detection) to toxicity and chemicals of concern, and in their ability to monitor data on an ongoing basis, recognising early threats and indicative patterns using AI." 

Microsaic notes that DeepVerge is a related party under the AIM Rules for Companies and its independent directors will review the details of any order(s) received from DeepVerge for its equipment when further details are made available in due course.

 

1 Microtox® PD has been designed to be retrofitted into existing Modern Water equipment to detect and identify a range of infectious viruses and bacteria including SARS-CoV-2, E.coli, Legionella and Cryptosporidium, on a single chip, using AI, in real-time

 

Enquiries:

Microsaic Systems plc

Glenn Tracey, CEO / Bevan Metcalf, FD

 

+44 (0)1483 751 577

Singer Capital Markets(Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / Tom Salvesen / George Tzimas 

 

Turner Pope Investments (TPI) Limited(Joint Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

About Microsaic

Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow.

 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. DeepVerge is utilising artificial intelligent data analytics to prove scientifically the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and to detect remotely, and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMMBRTMTJTBMB
Date   Source Headline
28th Oct 20149:16 amRNSHolding(s) in Company
14th Oct 20142:10 pmRNSHolding(s) in Company
10th Oct 20144:19 pmRNSHolding(s) in Company
10th Oct 20141:15 pmRNSExercise of Share Options
8th Oct 20147:00 amRNSDirectors' Dealings
7th Oct 20147:00 amRNSConditional Placing to Raise £4.4 million
30th Sep 20147:00 amRNSInterim Results
29th Sep 201412:23 pmRNSCommercial Agreement with Gilson Inc.
25th Sep 20147:00 amRNSMicrosaic Systems Signs Commercial Agreement
9th Sep 20147:00 amRNSPlexus chosen as commercial manufacturing partner
15th Jul 201410:06 amRNSDirectorate Change
23rd Jun 20143:08 pmRNSHolding(s) in Company
19th Jun 201412:02 pmRNSHolding(s) in Company
13th Jun 20149:00 amRNSDISTRIBUTION OF ANNUAL REPORT & ACCOUNTS
10th Jun 20149:10 amRNSExercise of share options
3rd Jun 20147:00 amRNSResult of AGM
30th May 20141:09 pmRNSNotification of Major Interest in Shares
6th May 201411:58 amRNSGRANT OF SHARE OPTIONS
30th Apr 20147:00 amRNSPreliminary Results
28th Apr 201412:33 pmRNSNotification of Major Interest in Shares
23rd Apr 20148:18 amRNSNotification of Major Interest in Shares
17th Apr 20149:19 amRNSHolding(s) in Company
15th Apr 20149:17 amRNSAppointment of Finance Director
14th Apr 20149:42 amRNSRe Agreement
11th Dec 20133:56 pmRNSHolding(s) in Company
21st Oct 20137:00 amRNSFormation of new Scientific Advisory Group
27th Sep 20137:00 amRNSInterim Results
1st Jul 20137:00 amRNSAppointment of Chairman
24th Jun 20137:00 amRNSIssue of Equity
4th Jun 20135:08 pmRNSHolding(s) in Company
4th Jun 20137:00 amRNSMicrosaic welcomes launch of the IsoleraT Dalton
31st May 201310:28 amRNSHolding(s) in Company
28th May 20132:44 pmRNSHolding(s) in Company
24th May 201311:23 amRNSResults of General Meeting
15th May 201311:23 amRNSResults of Annual General Meeting
7th May 20134:35 pmRNSDistribution of Circular of General Meeting
3rd May 20136:25 pmRNSConditional Placing to Raise up to £4.28 million
22nd Apr 20137:00 amRNSDistribution of Annual Report and Accounts
15th Apr 20137:00 amRNSPreliminary Results
10th Apr 20137:00 amRNSSigning of commercial agreement
15th Mar 20131:05 pmRNSHolding(s) in Company
14th Mar 20139:00 amRNSLaunch New Chip-based Mass Spectrometry Instrument
12th Dec 20129:36 amRNSGrant of Share Options
19th Oct 20124:45 pmRNSDirector/PDMR Shareholding
15th Oct 20122:26 pmRNSDirector/PDMR Shareholding
24th Sep 20127:00 amRNSAppointment of new CEO
24th Sep 20127:00 amRNSInterim Results
4th Sep 201210:00 amRNSAgreement
4th Jul 20129:46 amRNSGrant of Share Options
25th Jun 201210:29 amRNSMicrosaic Wins R&D100 Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.